Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.74 | 1.67 |
NAV | ₹85.11 | ₹214.64 |
Fund Started | 15 Apr 2009 | 20 Aug 2004 |
Fund Size | ₹9944.67 Cr | ₹15520.74 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 28.81% | 25.70% |
3 Year | 20.68% | 24.45% |
5 Year | 24.06% | 22.61% |
1 Year
3 Year
5 Year
Equity | 94.25% | 83.32% |
Cash | 4.52% | 16.35% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.89% |
HDFC Bank Ltd. | 7.38% |
Axis Bank Ltd. | 6.08% |
Sun Pharmaceutical Industries Ltd. | 5.72% |
Ultratech Cement Ltd. | 4.43% |
Larsen & Toubro Ltd. | 3.75% |
Dabur India Ltd. | 3.48% |
Cummins India Ltd. | 3.25% |
Bharti Airtel Ltd. | 3.24% |
Zydus Lifesciences Ltd. | 3.20% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.49% |
ICICI Bank Ltd. | 9.21% |
Axis Bank Ltd. | 8.35% |
Maruti Suzuki India Ltd. | 4.46% |
SBI Life Insurance Company Ltd. | 4.17% |
Cipla Ltd. | 4.15% |
Kotak Mahindra Bank Ltd. | 3.98% |
HCL Technologies Ltd. | 3.81% |
Bharti Airtel Ltd. | 3.67% |
Piramal Pharma Ltd. | 3.64% |
Name | Vaibhav Dusad | Dhruv Muchhal |
Start Date | 02 May 2020 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 15 Apr 2009 | 20 Aug 2004 |
Description
Launch Date